Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Breast Cancer × Safety × 1 year × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Mesothelioma, Malignant 1 Advanced Breast Cancer 1

Interventions

Fulvestrant 4 Letrozole 3 trastuzumab deruxtecan 2 sacituzumab govitecan 2 palbociclib 2 talazoparib 1 pyrotinib 1 olaparib 1 eribulin 1 elacestrant 1 disitamab vedotin 1 dalpiciclib 1 abemaciclib 1 Vinorelbine 1 Sirolimus 1 Safety 1 Ritonavir 1 Itraconazole 1 Docetaxel 1 Bevacizumab 1 Aromatase Inhibitors 1 Anastrozole 1 Alpelisib 1 AZD9833 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06926088 2025-04-13

CAMELIA

The First Affiliated Hospital with Nanjing Medical University

Active not recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡